Antidepressants and suicide risk: How did specific information in FDA safety warnings affect treatment patterns?

Psychiatric Services

Volumn 61, Issue 1, 2010, Pages 11-16

  Busch, Susan H ^a   Frank, Richard G ^b   Leslie, Douglas L ^c   Martin, Andrés ^d   Rosenheck, Robert A ^d   Martin, Erika G ^e   Barry, Colleen L ^a  

^a YALE UNIVERSITY   (United States)

^b HARVARD MEDICAL SCHOOL   (United States)

^c PENNSYLVANIA STATE UNIVERSITY   (United States)

^d YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e STATE UNIVERSITY OF NEW YORK   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUOXETINE; MONOAMINE OXIDASE INHIBITOR; PAROXETINE; SEROTONIN UPTAKE INHIBITOR; TRICYCLIC ANTIDEPRESSANT AGENT;

ARTICLE; CHILD; DRUG APPROVAL; DRUG EFFICACY; DRUG INDUSTRY; DRUG INFORMATION; DRUG LABELING; DRUG SAFETY; DRUG USE; FEMALE; FOLLOW UP; FOOD AND DRUG ADMINISTRATION; HIGH RISK PATIENT; HUMAN; INTERNATIONAL CLASSIFICATION OF DISEASES; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; OUTCOME ASSESSMENT; OUTPATIENT; PATIENT MONITORING; PEDIATRICS; PEER REVIEW; PRESCRIPTION; PSYCHIATRIC DIAGNOSIS; PSYCHOTHERAPY; PUBLIC HEALTH; RISK BENEFIT ANALYSIS; RISK MANAGEMENT; SUICIDAL IDEATION; SUICIDE; SUICIDE ATTEMPT; TREATMENT INDICATION;

EID: 74849133022     PISSN: 10752730     EISSN: 15579700     Source Type: Journal    
DOI: 10.1176/ps.2010.61.1.11     Document Type: Article

References (19)

1. Treatment for Adolescents With Depression Study Team: Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression. JAMA 292:807-820, 2004
2. Brent DA: Antidepressants and pediatric depression: the risk of doing nothing. New England Journal of Medicine 351:1598-1599, 2004
3. Libby AM, Brent DA, Morrato EH, et al: Decline in treatment of pediatric depression after FDA advisory on risk of suicidality with SSRIs. American Journal of Psychiatry 164:884-891, 2007
4. Nemeroff CB, Kalali A, Keller MB, et al: Impact of publicity concerning pediatric suicidality data on physician practice patterns in the United States. Archives of General Psychiatry 64:466-472, 2007
5. Olfson M, Marcus SC, Druss BG: Effects of Food and Drug Administration warnings on antidepressant use in a national sample. Archives of General Psychiatry 65:94-101, 2008
6. Rosack J: New data show declines in antidepressant prescribing. Psychiatric News, Sept 2, 2005, p 1
7. Harris G: Study finds less youth antidepressant use. New York Times, Sept 21, 2004
8. Gibbons RD, Brown CH, Hur K, et al: Early evidence on the effects of regulators' suicidality warnings on SSRI prescriptions and suicide in children and adolescents. American Journal of Psychiatry 164:1356-1363, 2007
9. Bridge JA, Greenhouse JB, Weldon AH: Suicide trends among youths aged 10 to 19 years in the United States, 1996-2005. JAMA 300:1025-1026, 2008
10. Valuck RJ, Libby AM, Orton HD, et al: Spillover effects on treatment of adult depression in primary care after FDA advisory on risk of pediatric suicidality with SSRIs. American Journal of Psychiatry 164:1198-1205, 2007
11. Morrato EH, Libby AM, Orton HD, et al: Frequency of provider contact after FDA advisory on risk of pediatric suicidality with SSRIs. American Journal of Psychiatry 165:42-50, 2008
12. Wingert TD, Kralewski JE, Lindquist TJ, et al: Constructing episodes of care from encounter and claims data: some methodological issues. Inquiry 32:430-443, 1995
13. Keeler EB, Wells KB, Manning WG, et al: The Demand for Episodes of Mental Health Services. Report R-3432-NIMH. Santa Monica, Calif, RAND, 1986
14. Wells KB, Roland S, Sherbourne CD, et al: Caring for Depression: A RAND Study. Cambridge, Mass, Harvard University Press, 1996
15. Kleinman LC, Norton EC: What's the risk? A simple approach for estimating adjusted risk measures from nonlinear models including logistic regression. Health Services Research 44:288-302, 2009
16. Barry CL, Busch SH: News media coverage of FDA warnings on pediatric antidepressant use. Pediatrics, in press
17. Olfson M, Marcus S, Weissman MM, et al: National trends in the use of psychotropic medications by children. Journal of the American Academy of Child and Adolescent Psychiatry 41:514-521, 2002
18. Zito JM, Safer JD, DosReis S, et al: Psychotropic practice patterns for youth: a 10-year perspective. Archives of Pediatric and Adolescent Medicine 157:17-25, 2003
19. Ma J, Lee KV, Stafford R: Depression treatment during outpatient visits by US children and adolescents. Journal of Adolescent Health 37:434-442, 2005 20. Kessler, RC, Demler O, Frank RG, et al: Prevalence and treatment of mental disorders, 1990-2003. New England Journal of Medicine 352:2515-2523, 2005